PGM3 and Global developmental delay: Patients with PGM3 mutations are reported to carry a high risk of early onset neurological impairment including developmental delay, ataxia, dysarthria, psychomotor retardation, hypotonia, sensorineural hearing loss, seizures and myoclonus (34, 41).